Physical mechanisms and methods employed in drug delivery to tumors
By: Erim Bešić
Open Access
|Sep 2007References
- R. G. Fenton and D. I. Longo,, in(Eds. A. S. Fauci, E. Braunwald, D. L. Kasper, S. L. Hauser, D. L. Longo and J. L. Jameson), 14ed., Vol, McGraw Hill, New York 1998, pp. 505--511.
- J. L.-S. Au, S. H. Jang, J. Zheng, C.-T. Chen, S. Song, L. Hu and M. G. Wientjes, Determinants of drug delivery and transport to solid tumors,(2001) 31--46; DOI: 10.1016/0168-3659(01)00308-2.
- H. Maeda and Y. Matsumura, Tumotropic and lymphotropic principles of macromolecular drugs,(1989) 183--210.
- K. Ulbrich, T. Etrych, P. Chytil, M. Jelenkova and B. Rihova, HPMA copolymers with pH-controlled release of doxorubicin.cytotoxicity and antitumor activity,(2003) 33--47; DOI: 10.1016/0168-3659(02)00348-6.
- Y. J. Son, J.-S. Jang, Y. W. Cho, H. Chung, R.-W. Park, I. C. Kwon, I.-S. Kim, J. Y. Park, S. B. Seo, C. R. Park and S. Y. Jeong, Biodistribution and antitumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect,(2003) 135--145; DOI: 10.1016/0168-3659(03)00231-1.
- S. S. Dharap, B. Qui, G. C. Williams, P. Sinko, S. Stein and T. Minko, Molecular targeting of the drug delivery systems to ovarian cancer by BH3 and LHRH peptides,(2003) 61--73; DOI: 10.1016/0168-3659(02)00209-8.
- Y. Sadzuka, R. Hirota and T. Sonobe, Interperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination,(2000) 51--59; DOI: 10.1016/0378-4274(00)00201-0.
- K. Greish, T. Sawa, J. Fang, T. Akaike and H. Maeda, MA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumors,(2004) 219--230; DOI: 10.1016/j.conrel.2004.03.027.
- T. Nakanishi, S. Fukushima, K. Okamoto, M. Suzuki, Y. Matsumura, M. Yokoyama, T. Okano, Y. Sakurai and K. Kataoka, Development of the polymeric micelle carrier system for doxorubicin,(2001) 295--302; DOI: 10.1016/0168-3659(01)00341-8.
- D. L. Garrec, M. Ranger and J. C. Leroux, Micelles in anticancer drug delivery,(2004) 15--42; DOI: 10.1175.9038(04)0002-1.
- T. Tamura, F. Fujita, M. Tanimoto, M. Koike, A. Suzuki, M. Fujita, Y. Horikiri, Y. Sakamoto, T. Suzuki and H. Yoshino, Antitumor effect of interperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice,(2002) 295--307; DOI: 10.1016/0168-3659(02)00003-2.
- J. S. Chawla and M. M. Amiji, Biodegradable poly(-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen,(2002) 127--138; DOI: 10.1016/0378-5173(02)00483-0.
- J. S. Chawla and M. M. Amiji, Cellular uptake and concentrations of tamoxifen upon administration in poly(-caprolactone) nanoparticles,(2003) Article 3; DOI: 10.1208/ps050103.
- C. Fonseca, S. Siomes and R. Gaspar, Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization andantitumoral activity,(2002) 273--286; DOI: 10.1016/0168-3659(02)00212-2.
- J. H. Poupaert and P. Couvreur, A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles,(2003) 19--26; DOI: 10.1016/0168-3659(03)00177-9.
- L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra and R. S. R. Murthy, Influence and administration route on tumor uptake and biodistribution of etoposide loaded tripalmitin nanoparticles in Dalton's lymphoma tumor bearing mice,(2005) 185--198; DOI: 10.1016/j.conrel.2005.02.028.
- J. Williams, R. Lansdown, R. Sweitzer, M. Romanowski, R. Labell, R. Ramaswami and E. Unger, Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors,(2003) 167--172; DOI: 10.1016/0168-3659(03)00241-4.
- W. Vogelhuber, T. Spruss, G. Bernhardt, A. Buschauer and A. Göpferich, Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts,(2002) 111--121; DOI: 10.1016/0378-5173(02)00061-3.
- H. Maeda, K. Greish and J. Fang,, in(Eds. R. Satchi-Fainaro and R. Duncan), Springer-Verlag, Berlin 2006, pp. 103--121.
- H. Maeda, J. Wu, T. Sawa, Y. Matsumura and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics,(2000) 271--284; DOI: 10.1016/0168-3659(99)00248-5.
- A. K. Iyer, G. Khaled, J. Fang and H. Maeda, Exploiting the enhanced permeability and retention effect for tumor targeting,(2006) 812--818; DOI: 10.1016/j.drudis.2006.07.005.
- H. Maeda, T. Sawa and T. Kono, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS,(2001) 47--61; DOI: 10.1016/0168-3659(01)00309-1.
- B. A. Almond, A. R. Hadba, S. T. Freeman, B. J. Cuevas, A. M. York, C. J. Detrisac and E. P. Goldberg, Efficacy of mitoxantrone-loaded albinum microspheres for intratumoral chemotherapy of breast cancer,(2003) 147--155; DOI: 10.1016/0168-3659(03)00214-1.
- E. S. Casper, D. P. Kelsen, N. W. Alcock and J. L. Lewis, IP cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route,(1983) 235--238.
- E. S. Lee, K. Na and Y. H. Bae, Polymeric micelle for tumor pH and folate mediated targeting,(2003) 103--113; DOI: 10.1016/0168-3659(03)00239-6.
- P. V. Paranjpe, Y. Chen, V. Kholodovych, W. Welsh, S. Stein and P. J. Sinko, Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis andevaluation,(2004) 275--292; DOI: 10.1016/j.conrel.2004.08.030.
- M. O. Oyewumi and R. J. Mumper, Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles,(2003) 85--97; DOI: 10.1016/0378-5173(02)00587-2.
- A. S. E. Ojugo, P. M. J. McSheehy, D. J. O. McIntyre, C. McCoy, M. Stubbs, M. O. Leach, I. R. Judson and J. R. Griffiths, Measurement of intracellular pH of solid tumors in mice by magnetic resonance spectroscopy: a comparison of exogenousF andP probes,(1999) 495--504; DOI: 10.1002/(SICI)1099-1492(1999)12:8.
- S. K. Han, K. Na and Y. H. Bae, Sulfonamide base pH-sensitive polymeric micelles: physicochemical characteristics and pH dependant aggregation,(2003) 49--59; DOI: 10.1016/0927-7757(02)00389-8.
- K. Na, E. S. Lee and Y. H. Bae, Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH dependant cell interaction, internalization and cytotoxicity(2003) 3--13; DOI: 10.1016/0168-3659(02)00345-0.
- C. Lackey, O. Press, A. Hoffman and P. Stayton, A biomimetic pH-responsive polymer directs endosomal release and intracellualar delivery of an endocytosed antibody complex,(2002) 996--1001; DOI: 10.1109/bioconchem.2002.844619.
- N. Murthy, J. Campbell, N. Fausto, A. S. Hoffman and P. S. Stayton, Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs,(2003) 412--419; DOI: 10.1109/bioconchem.2003.733726.
- K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano and Y. Sakurai, Block copolymer micelles as vehicles for drug delivery,(1993) 119--132.
- A. Halperin and S. Alexander, Polymeric micelles: their relaxation kinetics,(1989) 2403--2412.
- A. Rolland, J. O'Mullane, P. Goddard, L. Brookman and K. Petrak, New macromolecular carriers for drugs,(1992) 1195--1208.
- K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto and G. S. Kwon, Doxorubicin-loaded poly(ethylene glycol)-poly(-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristic and biological significance,(2000) 143--153; DOI: 10.1016/0168-3659(00)00133-9.
- G. S. Kwon and K. Kataoka, Block copolymer micelles as long circulating drug vehicles,(1995) 295--309.
- A. V. Kabanov and V. Alakhov,, in(Eds. P. Alexandridis and B. Lindman), Elsevier, Amsterdam 1997, pp. 134--148.
- P. Alexandridis and T. A. Hatton, Poly(ethyleneoxide)-poly(propyleneoxide)-poly(ethyleneoxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics and modeling,(1995) 1--46; DOI: 10.1016/0927-7757(94)03028-1.
- N. Rapoport, Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery,(1999) 93--111; DOI: 10.1517/17425247.3.1.139.
- G. Husseini, G. Myrup, W. Pitt, D. Christensen and N. Rapoport, Factors affecting acoustically triggered release of drugs from polymeric micelles,(2000) 43-52; DOI: 10.1016/0168-3659(00)00278-9.
- N. Munshi, N. Rapoport and W. G. Pitt, Ultrasonic activated drug delivery from Pluronic P-105 micelles,(1997) 13--19; DOI: 10.1016/0304-3835(97)00218-8.
- A. Marin, M. Muniruzzaman and N. Rapoport, Mechanism of the ultrasonic activation of micellar drug delivery,(2001) 69--81; DOI: 10.1016/0168-3659(01)00363-7.
- A. Marin, H. Sun, G. Husseini, W. Pitt, D. Christensen and N. Rapoport, Drug Delivery in Pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake,(2002) 39--47; DOI: 10.1016/0168-3659(02)00262-6.
- N. Rapoport, A. Marin and D. Christensen, Ultrasound-activated micellar drug delivery,(2002) 37--46.
- M. D. Bednarski, J. W. Lee, M. R. Callstrom and K. C. Li,target-specific delivery of macromolecular agents with MR-guaded focused ultrasound,(1997) 263--268; DOI: 10.1148/radiol.2381042078.
- D. E. Tilley and W. Thumm,(with the applications to the life sciences), Cummings Publishing Co., Menlo Park 1994.
- R. E. Apfel,, in(Ed. P. D. Edmonts), Vol, Academic Press, New York 1981, pp. 356--413.
- J. Liu, T. N. Lewis and M. R. Prausnitz, Non-invasive assessment and control of ultrasound--mediated membrane permeabilization,(1988) 918--924.
- L. B. Feril, T. Kondo and Q. L. Zhao, Enhancement of ultrasound-induced apoptosis and cell lysis by echo contrast agents,(2003) 331--337; DOI: 10.1016/0301-562(02)00700-7.
- V. Frenkel, A. Etherington, M. Greene, J. Quijano, J. W. Xie, F. Hunter, S. Dromi and K. C. P. Li, Delivery of liposomal doxorubicin in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure,(2006) 469--479; DOI: 10.1016/j.acra.2005.08.024.
- N. M. Emanuel, G. N. Bogdanov and V. S. Orlov, Free-radical mechanisms in the cytotoxic action of antitumor antibiotics,(1984) 1121--1138.
- N. Rapoport, W. G. Pitt, H. Sun and J. L. Nelson, Drug delivery in polymeric micelles: from(2003) 85--95; DOI: 10.1016/0168-3659(03)00218-9.
- E. Bešić, K. Sanković, V. Gomzi and J. N. Herak, Sigma radicals in gamma-irradiated single crystals of 2-thiothymine,(2001) 2723--2725; DOI: 10.1039/6103210k.
- K. Sanković, E. Malinen, J. N. Herak, Z. Medunić and E. Sagstuen, Hole transfer in crystals of cytosyne monohydrate: an EPR study,(2003) 1665--1670; DOI: 10.1039/b211108j.
- D. Krilov, A. Lekić, E. Bešić and J. N. Herak, EPR study of a copper center in a single crystal of cytosine monohydrate,(2005) 886--889; DOI: 10.1016/j.inorgbio.2005.01.001.
- E. Bešić, V. Gomzi, K. Sanković, J. N. Herak and D. Krilov, EPR study of a copper impurity center in a single crystal of 2-thiothymine,(2005) 2803--2808; DOI: 10.1016/j.saa.2004.10.026.
- M. Gabričević, E. Bešić, M. Biruš, A. Zahl and R. Van Eldik, Oxidation of hydroxyurea with oxovanadium(V) ions in acidic aqueous solution,(2006) 1606--1613; DOI: 10.1016/j.inorgbio.2006.05.008.
- B. Nigović, N. Kujundžić and K. Sanković, Electron transfer in-hydroxyurea complexes with iron(III),(2005) 51--55; DOI: 10.1016/j.ejmech.2004.09.012.
- N. Rapoport, J. N. Heron, W. G. Pitt and L. Pitina, Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound in the intracellular drug uptake,(1999) 153--162; DOI: 10.1016/0168-3659(98)00149-7.
- V. Mišik and P. Riesz, Recent application of EPR and spin trapping to sonochemical studies of organic liquids and aqueous solutions,(1996) 173--186; DOI: 10.1016/1350-4177(96)00023-5.
- V. Mišik and P. Riesz, EPR characterization of free radical intermediates formed during ultrasound exposure of cell culture media,(1999) 936--943; DOI: 10.1016/0891-5849(98)00282-2.
- T. Yu, J. Bai, K. Hu and Z. Wang, The effect of free radical scavenger and antioxidant on the increase in intracellular adriamycin accumulation induced by ultrasound,(2003) 33--35; DOI: 10.1016/1359-4177(02)00105-0.
- C. X. Deng, F. Sieling, H. Pan and J. Cui, Ultrasound-induced cell membrane porosity,(2004) 519--526; DOI: 10.1016/j.ultramedbio.2004.01.005.
- P. H. Zhou, Y. Izadnegahdar, J. M. Cui and C. X. Deng, Study of sonoporation dynamics affected by ultrasound duty cycle,(2005) 849--856; DOI: 10.1016/j.ultra medbio.2005.03.014.
- M. De Cuyper and M. Joniau, Magnetoliposomes: formation and structural characterization,(1988) 311--319.
- A. Jordan, R. Scholz, K. Maier-Hauff, M. Johannsen, P. Wust, J. Nadobny, H. Schirra, H. Schmidt, S. Deger, S. Loening, W. Lanksch and R. Felix, Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia,(2001) 118--126; DOI: 10.1016/0304-8853(01)01239-7.
- A. Jordan, P. Wust, R. Scholz, B. Tesche, H. Fahling, T. Mitrovics, T. Vogl, J. Cervos-Navarro and R. Felix, Cellular uptake of magnetic fluid particles and their effect on human adenocarcinoma cells exposed to AC magnetic fields(1996) 705--722; DOI: 10.1080/765134545521.
- M. Babincova, V. Altanerova, M. Lampert, C. Altaner, E. Machova, M. Sramka and P. Babinec, Site-specifictargeting of magnetoliposomes using externally applied magnetic field,(2000) 278--281; DOI: 10.1089/109662002760178159.
- J. Q. Zhang, Z. R. Zhang, H. Yang, Q. Y. Tan, S. R. Qin and X. L. Qiu, Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parental administration:andstudies,(2005) 573--583; DOI: 10.1007/s11095-005-2496-8.
- M. Babincova, P. Cicmanec, V. Altanerova, C. Altaner and P. Babinec, AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy,(2002) 1--19; DOI: 10.1016/s1567-5394(01)00166-9.
- T. Kubo, T. Sugita, S. Shimose, Y. Niita, Y. Ikuta and T. Murakami, Targeted delivery of anticancer drugs with intravenously administrated magnetic liposomes in osteosarcoma-bearing hamsters,(2000) 309--315; DOI: 10.1111/j.1525-1438.2000.00168.
- M. Kullberg, K. Mann and J. L. Owens, Improved drug delivery to cancer cells: a method using magnetoliposomes that target epidermal growth factor receptors,(2005) 468--470; DOI: 10.1016/j.mehy.2004.07.033.
- K. Y. Ng, C. W. Cho, T. K. Henthorn and R. L. Tanguay, Effect of heat preconditioning on the uptake and permeability of R123 in brain microvessel endothelial cells during mild heat treatment,(2004) 896--907; DOI: 10.1002/jps.20015.
- K. Trieb, A. Sztankay, A. Amberger, H. Lechner and B. Grubeckloebenstein, Hyperthermia inhibits profileration and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells,(1994) 65--71; DOI: 10.1016/0304-3835(94)90410-3.
- K. M. Sekins, D. B. Leeper, J. K. Hoffman, M. R. Wolfson and T. H. Shaffer, Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia,(2004) 252--277; DOI: 10.1080/02656730310001605537.
- B. Guo, L. Z. Xu and J. Li, Time reversal based microwave hyperthermia treatment of breast cancer,(2005) 335--338; DOI: 10.1002/mop.1378.
- S. Ahmed, B. Lindsey and J. Davies, Emerging minimally invasive techniques for treating localized prostate cancer,(2005) 1230--1234; DOI: 10.1111/j.1464-4100.2005.05742.
- H. Sakurai, K. Hayakawa, N. Mitsuhashi, Y. Tamaki, Y. Nakayama, H. Kurosaki, S. Nasu, H. Ishikawa, J. I. Saitoh, T. Akimoto and H. Niibe, Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion,(2002) 472--483; DOI: 10.1080/02656730210146917.
- M. D. Sherar, J. Trachtenberg, S. R. H. Davidson, C. McCann, C. K. K. Yue, M. A. Haider and M. R. Gertner, Interstitial microwave thermal therapy for prostate cancer,(2003) 617--625; DOI: 10.1111/j.1464-4100.2003.05848.
- P. R. Stauffer, Evolving technology for thermal therapy of cancer,(2005) 731--744; DOI: 10.1080/02656730500331868.
- I. Hilger, E. Dietmar, W. Linss, S. Streck and W. A. Kaiser, Developments for the minimally invasive treatment of tumors by targeted magnetic heating,(2006) 2951--2958; DOI: 10.1080/0953-8984/18/38/28.
- M. Johannsen, B. Thiesen, A. Jordan, K. Taymoorian, U. Gneveckow, N. Waldofner, R. Scholz, M. Koch, M. Lein, K. Jung and S. A. Loening, Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model,(2005) 283--292; DOI: 10.1002/pros.20213.
- T. N. Brusentsova, N. A. Brusentsov, V. D. Kuznetsov and V. N. Nikiforov, Synthesis and investigation of magnetic properties of Gd-substituded Mn-Zn ferrite nanoparticles as a potential low-T-C agent for magnetic fluid hyperthermia,(2005) 298--302; DOI: 10.1016/j.jmmm.2005.02.023.
- T. Neuberger, B. Schopf, H. Hofmann, M. Hofmann and B. Rechenberg, Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system,(2005) 483--496; DOI: 10.1016/j.jmmm.2005.01.064.
- S. Y. Yan, D. S. Zhang, N. Gu, J. Zheng, A. W. Ding, Z. Y. Wang, B. L. Ying, M. Ma and Y. Zhang, Therapeutic effect of FeOnanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers,(2005) 1185--1192; DOI: 10.1116/jnn.2005.219.
- O. Dudeck, K. Bogusiewicz, J. Pinkernelle, G. Graffke, M. Pech, G. Wieners, H. Bruhn, A. Jordan and J. Ricke, Local arterial infusion of superparamagnetic iron oxide particles in hepatocellular carcinoma — feasibility and 3.0 T MRI study,(2006) 527--535; DOI: 10.1097/01.rli.0000209601.15533.5a.
- M. Johannsen, B. Thiesen, U. Gneveckow, K. Taymoorian, N. Waldofner, R. Scholz, S. Deger, K. Jung, S. A. Loening and A. Jordan, Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer,(2006) 97--104; DOI: 10.1002/pros.20316.
- M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S. A. Loening and A. Jordan, Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique,(2005) 637--647; DOI: 10.1080/02656730500158360.
- M. Belehradek, C. Domenge, B. Luboinski, S. Orlowski, J. Belehradek and L. M. Mir, Electrochemotherapy, a new anti-tumor treatment: first clinical phase I-II trial report,(1993) 3694--3700; DOI: 10.1002/0305-7372(93)00073-2.
- J. Teissie and M. P. Rols,, in(Eds. M. J. Allen, S. F. Cleary, A. E. Sowers and D. Shillady), Vol., Birkhauser, Boston 1992, pp. 285--301.
- A. Gothelf, L. M. Mir and J. Gehl, Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation,(2003) 371--387; DOI: 10.1016/0305-7372(03)00073-2.
- S. Orlowski, J. Belehradek, C. Paoletti and L. M. Mir, Transient electropermeabilization of cell in culture: increase of the cytotoxicity of anticancer drugs,(1988) 4727--4733.
- J. Gehl, T. Skovsgaard and L. M. Mir, Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs,(1998) 319--325.
- M. J. Jaroszeski, R. Gilbert, R. Perrott and R. Heller, Enhanced effects of multiple treatment electrochemotherapy,(1999) 427--433; DOI: 10.1097/0305737203000732.
- C. Domenge, S. Orlowski, B. Luboinski, T. DeBaere, G. Schwaab, J. Belehradek and L. M. Mir, Antitumor electrochemotherapy,(1996) 956--963; DOI: 10.1002(SICI)1097-0142 (19960301) 77:5.
- O. Tounekti, G. Pron, J. Belehradek and L. M. Mir, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized,(1993) 5462--5469; DOI: 10.1158/5472(93)7693342.019.
- D. W. Jordan, M. D. Uhler, R. M. Gigenbach and Y. Y. Lau, Enhancement of cancer chemotherapy by intense ultrawideband electric field pulses,(2006) 94701--94706; DOI: 10.1063/1.2195421.
- C. M. Byrne, J. F. Thompson, H. Johnston, P. Hersey, M. J. Quinn, T. M. Hughes and W. H. McCarthy, Treatment of metastatic melanoma using electroporation therapy with bleomycin,(2005) 45--51; DOI: 10.1097/00008390-200502000-000008.
- G. Sersa, T. Cufer, M. Cemezar, M. Rebersek and R. Zvonimir, Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis,(2006) 163--165.
- J. Larkin, D. Soden, C. Collins, M. Tangney, J. M. Preston, L. J. Russell, A. P. McHale, C. Dunne and G. C. O'Sullivan, Combined electric field and ultrasound therapy as a novel antitumor treatment,(2005) 1339--1348; DOI: 10.1016/j.ejca.2005.01.025.
- A. M. R. Haro, A. Smyth, P. Hughes, C. N. Reid and A. P. McHale, Electro-sensitation of mammalian cells and tissues to ultrasound: a novel treatment modality,(2005) 49--55; DOI: 10.1016/j.canlet.2004.09.011.
- J. F. Kolb, S. Kono and K. H. Schoenbach, Nanosecond pulsed electric field generators for the study of subcellular effects,(2006) 172--187; DOI: 10.1002/bem.20185.
- R. Nuccitelli, U. Pliquett, X. H. Chen, W. Ford, R. J. Swanson, S. J. Beebe, J. F. Kolb and K. H. Schoenbach, Nanosecond pulsed electric fields cause melanomas to self-destruct,(2006) 351--360; DOI: 10.1016/j.bbrc.2006.02.181.
- R. Giardino, M. Fini, V. Bonazzi, R. Cadossi, A. Nicolini and A. Carpi, Electrochemotherapy, a novel approach to the treatment of metastatic nodules on the skin and subcutaneous tissues.(2006) 458--462; DOI: 10.1111/j.1600-0846.2006.00100.
Language: English, Croatian
Page range: 249 - 268
Published on: Sep 18, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2007 Erim Bešić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.